BDNF and endometrial cancer: It therefore seems that increased risk of breast and endometrial cancer often occurred in estrogen therapy may be related to its enhancement effects on peripheral neurotrophins (48, 49), and the potential better safety profile of JYP observed in this study is, at least in part, derived from it tissue-specific effects on neurotrophins, particularly without effects on uterine neurotrophins.